Pain
Depressive Symptoms and Pain in Older Veterans: What’s the Link?
Researchers sought to examine the relationship between depressive symptoms and pain in U.S. veterans 50 years of age or older.
Your search for major depressive disorder returned 16 results
Neurobehavioral Disorders
Replicating Neuroimaging Abnormalities in Major Depression
Convergent abnormalities were observed in secondary analyses across portions of the amygdala, hippocampus, subgenual cingulate cortex, and putamen.
Multiple Sclerosis
Shared Underlying Pathways Found for Fatigue and Depression in MS
Proinflammatory cytokines, tryptophan catabolites, and the gut-brain axis may have key roles in chronic fatigue and depression in patients with multiple sclerosis.
Neurobehavioral Disorders
Aspirin Does Not Prevent Late Life Depression, Despite Link to Inflammation
Depression has been linked to elevated markers of inflammation, and aspirin, a nonsteroid, anti-inflammatory medication, can irreversibly inhibit cyclooxygenase-1 and 2.
Migraine and Headache
Psychiatric Comorbidities Predict Treatment Outcomes for Idiopathic Intracranial Hypertension
The presence of psychiatric disorders in patients with idiopathic intracranial hypertension is associated with poor treatment outcomes.
Pediatric Neurology
Positive Family Environment May Mitigate Depression Risk in Mothers of Children With Epilepsy
Investigators predicted the prevalence of depressive symptoms among mothers over the first 10 years after their children were diagnosed with epilepsy and identified trajectories of maternal depressive symptoms over time and baseline characteristics related to each trajectory.
Multiple Sclerosis
B-Cell Depletion Influences SARS-CoV-2 Antibody Production in Patients With MS
In order to assess asymptomatic infections and immunologic responses to COVID-19, a team of researchers tested for SARS-CoV-2 antibodies in a multiple sclerosis cohort.
Migraine and Headache
Galcanezumab Reduces Migraine Days and Disabling Nonpain Symptoms
Study investigators sought to determine if galcanezumab would reduce not only the frequency of migraine days but also the disabling nonpain symptoms of episodic and chronic migraine.
Sleep Disorders
Longitudinal Changes in Dopamine Transporter Predict Neurodegenerative Risk in iRBD
Longitudinal changes in the dopamine transporter availability may identify patients with idiopathic REM sleep behavior disorder who are at risk of conversion to neurodegenerative diseases.
Alzheimer's Disease and Dementia
Pimavanserin Reduces Delusions and Relapse Risk in Dementia-Related Psychosis
Analysis of the HARMONY trial was conducted to evaluate the prevention of relapse in patients with dementia-related psychosis who have been treated with pimavanserin.
- Loading...
Loading...
Next post in Alzheimer's Disease and Dementia
Loading... 
Loading...